CDH17 and neoplasm: Similar to CDH17, it is significantly overexpressed in colorectal cancer and is distributed across the apical membrane and basolateral membrane of tumor cells, disrupting the tight junctions of the tumor cells, which is beneficial for interaction with targeted therapies [22].